https://statticinhibitor.com/m....odelling-activity-an
We consider two potential methods for modifying SWEET's current approach to address this dilemma. We additionally consider the merits of KIND abandoning its present way of equity weighting and following a standard 'net benefit' method in its place. We discover that adopting a typical 'net advantage' approach is one of desirable alternative, since it provides for more transparency while preventing particular problems that arise when wanting to change KIND's present approach. Regard